Skip to main content
Fig. 5 | Bioelectronic Medicine

Fig. 5

From: A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms

Fig. 5

Long-COVID Symptom Improvement by Randomization Group. In this small sample, taVNS reduced the mean percent of Long-COVID symptoms experienced by participants. During the two-week blinded period, sham taVNS provided no benefit to participants, however during the open label period, those individuals reduced their Long-COVID symptom burden. In the initial active group, we see a marked reduction in Long-COVID symptoms over the course of treatment and follow-up

Back to article page

Bioelectronic Medicine

ISSN: 2332-8886